Objective: To determine the effects of interleukin (IL)-17A inhibition on experimental atherosclerosis.
Methods And Results: ApoE(-/-) mice were treated with either rat anti-mouse IL-17A, mouse anti-mouse IL-17A or isotype-matched control antibodies for 12 weeks (n=8-10 per group). Ldlr(-/-) mice were transplanted with IL-17A-deficient or wild type bone marrow (n=8 per group). Rat anti-mouse IL-17A treatment obviously reduced plaque size by 43% (p<0.01) without evidence of reduced IL-17A signaling. In contrast, mouse anti-mouse IL-17A treatment and IL-17A deficiency in bone marrow cells did not alter lesion size despite significant reduction of IL-17A production.
Conclusions: Inhibition of IL-17A signaling does not alter lesion development in Th1-biased C57BL/6 ApoE(-/-) and Ldlr(-/-) mice with already low levels of IL-17A production. Alteration of lesion development after repeated injections of rat anti-mouse IL-17A antibody in ApoE(-/-) mice could not be attributed to blockade of IL-17A signaling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.atherosclerosis.2010.12.034 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dual blockade of IL-17A and IL-36 pathways via a bispecific antibody exhibits enhanced anti-inflammatory potency.
Front Immunol
November 2024
Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China.
Antibody drugs targeting single inflammatory cytokines have revolutionized the treatment of immune-mediated inflammatory diseases. To investigate whether dual targeting interleukin-17 (IL-17) and IL-36 enhances anti-inflammatory activity, bispecific Ab HB0043 was generated by linking the single chain fragment variables (scFvs) from humanized anti-IL-36R antibody (HB0034) to the C-terminus of the heavy chain of anti-IL-17A IgG1 (HB0017) Fc using a flexible peptide linker. HB0043 largely maintained the binding affinities and biological activities of the two parent monoclonal antibodies (mAbs) .
View Article and Find Full Text PDF[The role and its regulatory significance of interleukin-25 in ovalbumin induced atopic dermatitis of mice].
Beijing Da Xue Xue Bao Yi Xue Ban
October 2024
Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
Article Synopsis
- The study aimed to explore how interleukin-25 (IL-25) affects atopic dermatitis in mice induced by ovalbumin (OVA) and the importance of IL-25 regulation.
- Researchers used 90 male BALB/c mice, injecting them with various treatments (like PBS, IL-25, anti-IL-25 antibodies, and OVA) over seven weeks to study their scratching behavior and skin conditions.
- Results showed that mice receiving IL-25 injections scratched more, indicating worse dermatitis, while those treated with anti-IL-25 antibodies scratched less, suggesting a protective effect against the dermatitis symptoms.
Scleroglucan protects the intestine from irradiation-induced injury by targeting the IL-17 signaling pathway.
Int Immunopharmacol
March 2024
School of Public Health and Management, Wenzhou Medical University, 325000 Wenzhou, China; Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai 200433, China. Electronic address:
Background: Intestinal tissue is extremely sensitive to ionizing radiation (IR), which is easy to cause intestinal radiation sickness, and the mortality rate is very high after exposure. Recent studies have found that intestinal immune cells and intestinal stem cells (ISCs) may play a key role in IR-induced intestinal injury.
Methods: C57BL6 mice matched for age, sex and weight were randomly grouped and intraperitoneal injected with PBS, Scleroglucan (125.
PI3Kγ controls IL-17A expression and attenuates alveolar bone loss in an experimental periodontitis model.
Inflamm Res
January 2023
Department of Physiological Sciences, Piracicaba Dental School, University of Campinas, Piracicaba, SP, Brazil.
Objective: In this study, we investigated the modulatory effects of PI3Kγ on IL-17A expression and the progression of experimental periodontitis in vivo.
Methods: Ligature-induced periodontitis was developed around the first molar of mice. Animals were treated with anti-mouse IL-17A or IPI-549 (PI3Kγ inhibitor).
Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice.
Egypt J Immunol
October 2022
Department of Medical Parasitology Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Schistosoma mansoni liver fibrosis is a complicated multicellular process involving numerous cytokines, chemokines, and growth factors. Transforming growth factor beta 1 (TGF-1) and interleukin (IL)-13 have been identified as critical pro-fibrotic mediators in many studies. IL-17A was linked to enhanced TGF- and IL-13-induced pathologies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!